MarketPeel
AL

Aimee J. Lenar

BHC
EVP, US PHARMA · BAUSCH HEALTH COMPANIES INC. · CIK 0002029927
FILING MIX · LIFETIME44%/56%
BUYS
4
SELLS
5
TOTAL VALUE
$650.8K
COMPANIES
1
ACTIVE SINCE
Jul 2024
HOLDINGS NOW
334,853
AVG SELL PX
$6.15
TRADE KIND
SHOWING 9 / 9
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Aimee J. Lenar. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
BHC · 334,853 shares · as of Aug 19, 2026
0104,478208,957313,435417,91320252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 4 buys / 5 sellsCOVERAGE · 9 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
BHC
BAUSCH HEALTH COMPANIES INC.
SALE10b5-1
10b5-1 plan
36,827$7.03$258.9K334,853Aug 19, 2026Aug 20, 2026View →
BHC
BAUSCH HEALTH COMPANIES INC.
SALE
President, US Pharma
5,260$4.83$25.4K371,680Jul 17, 2026Jul 20, 2026View →
BHC
BAUSCH HEALTH COMPANIES INC.
SALE
President, US Pharma
23,395$4.89$114.4K376,940Jul 15, 2026Jul 17, 2026View →
BHC
BAUSCH HEALTH COMPANIES INC.
SALE
EVP, US Pharma
17,578$6.04$106.2K400,335Feb 26, 2026Feb 27, 2026View →
BHC
BAUSCH HEALTH COMPANIES INC.
PURCHASEGRANT
Stock grant
157,139417,913Feb 25, 2026Feb 27, 2026View →
BHC
BAUSCH HEALTH COMPANIES INC.
PURCHASEGRANT
Stock grant
30,847260,774Jul 17, 2025Jul 18, 2025View →
BHC
BAUSCH HEALTH COMPANIES INC.
SALE
EVP, US Pharma
22,736$6.42$146.0K229,927Jul 15, 2025Jul 16, 2025View →
BHC
BAUSCH HEALTH COMPANIES INC.
PURCHASEGRANT
Stock grant
108,311252,663Feb 26, 2025Feb 28, 2025View →
BHC
BAUSCH HEALTH COMPANIES INC.
PURCHASEGRANT
Stock grant
144,352144,352Jul 15, 2024Jul 17, 2024View →
Other insiders · BHC
Loading peer insiders…
About this filer
CIK 0002029927
ROLE
EVP, US Pharma
PRIMARY
BHC
COMPANIES
1
ACTIVE SINCE
Jul 2024
MARKETPEEL · /INSIDER/0002029927DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback